The Effect of Narrative Exposure Therapy Intervention on Post-traumatic Stress Dissorder and Personal Recovery in Refugees and Asylum Seekers of Sindiane Programme
NCT ID: NCT05407337
Last Updated: 2024-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
46 participants
INTERVENTIONAL
2022-11-22
2024-04-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lifeline-NET (Narrative Exposure Therapy): A Short-term Treatment for Traumatized Refugees and Asylum Seekers
NCT01720732
Narrative Exposure Therapy for Adults With an Intellectual Disability
NCT06934109
The Development and Efficacy of a Recovery Group for People With Mental Illness
NCT04075838
Effects of Mindfulness Training on Memories of Personal Past Events
NCT05121116
Cognitive-behavioral Therapy for Mental Disorder in COVID-19 Survivors
NCT05815693
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective is the assessment of the symptom intensity score (PCL-5) of posttraumatic stress disorder (PTSD).
Secondary objectives are represented by:
* The assessment of the stability over time of the PTSD symptom intensity score at three months and six months (PCL-5).
* Assessment of the intensity of global psychiatric comorbidities (RHS-15)
* Evaluation of life indicators: ability to act, quality of life (GSE self-efficacy questionnaire).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Beneficiaries of NET therapy + standard Sindiane program management.
Psychotherapy using Narrative Exposure Therapy (NET)
There are four NET sessions, each lasting thirty minutes and defined in advance on a weekly basis. The first session is the one where the person concerned will establish his/her "Life Line" and start his/her life story with the peer mediator.
The second and third session will be the one where the person will continue his life story. Each session will begin with the mediator reading the story from the previous session, with the person concerned modifying the story if they wish.
The fourth session will also start with the reading of the story from the previous session and will finish the story if necessary. It will also be the occasion to give the printed story to the person concerned at the end of the session and have it signed by the mediator and the patient.
To prevent a possible risk of decompensation of the subject during the session, there will be a psychiatrist on site at the time of the NET to be available if the patient needs it.
Control group
Beneficiaries of the standard care of the Sindiane program.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Psychotherapy using Narrative Exposure Therapy (NET)
There are four NET sessions, each lasting thirty minutes and defined in advance on a weekly basis. The first session is the one where the person concerned will establish his/her "Life Line" and start his/her life story with the peer mediator.
The second and third session will be the one where the person will continue his life story. Each session will begin with the mediator reading the story from the previous session, with the person concerned modifying the story if they wish.
The fourth session will also start with the reading of the story from the previous session and will finish the story if necessary. It will also be the occasion to give the printed story to the person concerned at the end of the session and have it signed by the mediator and the patient.
To prevent a possible risk of decompensation of the subject during the session, there will be a psychiatrist on site at the time of the NET to be available if the patient needs it.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Refugee or asylum seeker (habing applied to OFFPRA or with a residence permit)
* Belonging to the SINDIANE community project
* Having been exposed to at least one traumatic event (according to the DSM 5 definition validated by a doctor)
* Having a PCL5 score greater than 23
* Agreeing to participate in the study with an informed consent signed by the subject after explanations given by the investigating psychiatrist
* Patient affiliated to a social security health care
* Patient able to read and write arabic or french
Exclusion Criteria
* Be included in another intervention research
* Presence of severe mental retardation or dementia according to DSM5
* Persons benefiting from special protection : under article L3212-1 and L3213-1 of the Public Health Code
* Persons referred to in articles L1121-5 to L1121-8 of the CSP
* Existence of a high suicide risk assessed by the R.U.D.
* Patient subject to a compulsory care measure (Law n°2011-803 of july 5, 2011 relating to the rights and protection of persons subject to psychiatric care and the terms of care)
* Patient refusing to sign the consent or unable to receive the information necessary to give informed consent
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François CREMIEUX
Role: STUDY_DIRECTOR
Assistance Publique Hôpitaux Marseille
Clotilde IZABELLE, Dr
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique Hôpitaux Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assistance Publique Hôpitaux Marseille
Marseille, Bouches-du-Rhône, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A01172-39
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.